Sanofi has launched a new initiative in its drive to integrate digital technologies ... first task for the accelerator will be to address the needs of patients with atopic dermatitis – a key ...

The Digital Medicine Society (DiME) is today releasing a new set of open-access resources to advance the use of nocturnal scratch in the treatment of atopic dermatitis (AD). Night-time flare-ups ...

Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) announced that the ... have been shown to co-morbidly occur with CSU, such as atopic dermatitis and asthma – providing patients with one ...

Drug is also being tested as a treatment for the skin condition atopic dermatitis, Sanofi’s next-generation experimental asthma drug failed to significantly reduce flare-ups in patients with ...